Early ART initiation confers several benefits on HIV-related morbidity and clinical outcomes and can lead to natural control of HIV replication upon ART interruption in a subset of individuals. We evaluated how timing of ART initiation impacts the size of the HIV reservoir during early infection in a subset of the Sabes study, a randomized clinical trial in Peru.
HIV-infected MSM and transgender women who were diagnosed while sero-negative (acute, n=12), or were sero-positive and <90 days from last negative RNA test (recent, n=16), were randomized to receive ART immediately (acute immediate [AI], n=8 and recent immediate [RI], n=11) or after 24 weeks deferral (D, n=9). We quantified total and integrated HIV DNA in CD4 T cells by real-time PCR, and used TILDA (Tat/rev Induced Limiting Dilution Assay) to measure the frequency of CD4 T cells producing multiply spliced RNA (msRNA) as a proxy for virus production, with and without stimulation.
As expected, viral loads measured before ART initiation (week 0: Acute & Recent, week 24: D) were significantly higher in the acute group compared to either recent or D groups (6.78, 5.71 and 5.05 log10 copies/ml, respectively, p<0.01 both comparisons). Total and integrated HIV DNA did not differ in the 3 groups prior to ART, although TILDA frequencies with and without stimulation were higher in the acute and recent groups than the D group (p<0.05 all comparisons). After 6 months of ART, levels of integrated HIV DNA were significantly lower in the AI group than in the RI group (p=0.03); the inducible reservoir measured by TILDA was smaller in the AI group than in the RI or D groups (p=0.005 and 0.02, respectively, Figure 1a). During the first 6 months of ART, all three measurements of HIV persistence decreased more in the AI group than in those treated later (Figure 1b, all p<0.02). The TILDA/integrated HIV DNA ratio at study entry and 24 weeks later were highly correlated (R=0.87, p<0.001), suggesting that the relative proportion of inducible and defective proviruses was maintained over 6 months.
ART initiation during acute infection limits the size of the inducible reservoir, but the apparent benefit does not extend to persons who initiated ART after seroconversion. Markers of HIV persistence had a steeper decay in acutely treated individuals than in the two groups treated slightly later. Initiating ART during acute infection may facilitate HIV remission in concert with additional eradication strategies.